Client Result
Carlyle and SK Capital to Acquire bluebird bio
1 minute read | March.07.2025

1 minute read | March.07.2025
1 minute read | May.06.2024
Meta prevails in important test of corporate law protections, earning Orrick recognition in Litigators of the Week.
1 minute read | May.02.2023
June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
September.29.2021
January.17.2019
June.15.2017
October.07.2016
August.23.2016
July.09.2014
An Orrick team Todd Scott and Alexander Talarides is identified as representing Chesapeake Energy Corp. in its defeat of a shareholder class action.